AMICUS THERAPEUTICS INC (FOLD)       10.24  +0.21 (+2.09%)

10.24  +0.21 (+2.09%)

US03152W1099 - Common Stock - After market: 10.24 0 (0%)

Buy % Consensus

81
Analysts have set a mean price target of 14.74. This target is 43.98% above the current price.
FOLD was analyzed by 18 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about FOLD.
In the previous month the buy percentage consensus was at a similar level.
FOLD was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 10.2410.1014.2814.7421.00 - -1.37% 39.45% 43.98% 105.08%

Up and Down Grades

Date Firm Action Rating
2022-09-09 Morgan Stanley Initiate Equal-Weight
2022-02-24 SVB Leerink Maintains Outperform
2022-01-14 SVB Leerink Upgrade Market Perform -> Outperform
2022-01-13 Cantor Fitzgerald Maintains Overweight
2021-11-15 Stifel Upgrade Hold -> Buy
2021-09-30 SVB Leerink Maintains Market Perform
2021-09-30 JP Morgan Upgrade Neutral -> Overweight
2021-05-27 Needham Initiate Hold
2021-05-21 UBS Initiate Buy
2021-04-14 Cantor Fitzgerald Upgrade Neutral -> Overweight
2021-03-22 SVB Leerink Maintains Market Perform
2021-03-02 Stifel Initiate Hold
2021-02-12 Cantor Fitzgerald Downgrade Overweight -> Neutral
2021-02-12 SVB Leerink Downgrade Outperform -> Market Perform
2021-02-12 JP Morgan Downgrade Overweight -> Neutral

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA